Ferentis - a member of the winning project consortium within the EuroNanoMed2 program

As part of the consortium, Ferentis will participate in the research project REGENERATE, which is targeted at developing a novel regenerative medicine and tissue engineering method to treat the limbal epithelial stem cells deficiency (LSCD) of eye cornea.  The winning project is funded by the EU ERA-NET program EuroNanoMed2.  The objective of the project is to develop a fully-transparent synthetic eye cornea alternative to donor corneas, with superior cell-interactive properties that circumvents the problems with current limbal stem cell delivery scaffolds.  

The 3 year REGENERATE project, co-ordinated by University Hospital Antwerp, Belgium, is comprised of 6 partners, scientific institutions and companies from Sweden, Israel and Lithuania.